AI-guided prioritization of potential FAM171A2 ligands through pharmacophore-aware and receptor-based screening
Year: 2026
Type: article
Abstract: profiles than the reference blocker Bemcentinib across complementary computational assessments: E634-1386 achieved higher KarmaDock and CarsiDock scores, whereas F707-2364 yielded the most favorable AutoDock Vina score and MM/GBSA estimate. Molecular dynamics simulations further suggested stable predicted FAM171A2-bound complexes for both candidates, with lower complex RMSD, reduced radius of gyration and lower protein solvent-accessible surface area relative to Bemcentinib, while maintaining broadly similar residue-level flexibility patterns. Representative interaction analysis suggested that E634-1386 may rely more on polar contacts, whereas F707-2364 may engage the predicted binding region through broader hydrophobic complementarity. Together, these results prioritize E634-1386 and F707-2364 as computationally selected, experimentally testable FAM171A2 ligand candidates and provide a practical strategy for early-stage ligand prioritization against structurally challenging central nervous system targets.
Source: RSC Advances
DOI: 10.1039/d6ra07609b
Authors: Baihui Yan, Yang Lu, Yanni Tong, Shaolong Lin, Wei Li
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,042
OpenAlex ID: W7225914125
